Hannah Sneyd in Washington, Washington DC

Home Washington DC Washington

Hannah Sneyd has Anesthesiology Assistant as her primary medical specialty. Their primary office is: 5255 Loughboro Rd Nw in Washington, Washington DC.

They're a part of the: Surgical Anesthesia Associates, Pllc medical group which has around 99 members. You can call their office at 202-537-4563 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, her university is not listed and graduated in 2020 (around 5 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Hannah Sneyd Office Phone and Directions

Hannah Sneyd
Surgical Anesthesia Associates, Pllc
5255 Loughboro Rd Nw
Washington, Washington DC 20016
202-537-4563

Patient Ratings
Please rate your experience with Hannah Sneyd below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 202-537-4563

Enter a starting address:

Healthcare Info for Hannah Sneyd

Medical School: Sorry, her university is not listed
Graduation Year: 2020
The Primary Medical Specialty for Hannah Sneyd is listed as: Anesthesiology Assistant
Approximate Years of Experience: 5
PAC (PECOS ID)#: 6608299078
NPI #: 1679196364
NPI Created On: 05/28/2020
NPI Last Updated Listed as: 05/28/2020
Primary Taxonomy Code: 367H00000X
Listed Gender: Female

Procedures, Services, Charges

Services and Procedures include:

Anesthesia for procedure on large bowel using an endoscope

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 849494121

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Pain Management

Name of Drug #1: Exparel

Open Associated Drug #1: 65250-266-09